These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 6258924)

  • 1. Human T-B lymphoblast hybrids express HLA-DR specificities not expressed by either parent.
    Howell DN; Berger AE; Cresswell P
    Immunogenetics; 1982; 15(2):199-206. PubMed ID: 6977490
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and identification of a cDNA clone corresponding to an HLA-DR antigen beta chain.
    Wiman K; Larhammar D; Claesson L; Gustafsson K; Schenning L; Bill P; Böhme J; Denaro M; Dobberstein B; Hammerling U; Kvist S; Servenius B; Sundelin J; Peterson PA; Rask L
    Proc Natl Acad Sci U S A; 1982 Mar; 79(6):1703-7. PubMed ID: 6952222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of T-lymphoblast-encoded HLA-DR antigens on human T-B lymphoblast hybrids.
    Howell DN; Cresswell P
    Immunogenetics; 1983; 17(4):411-25. PubMed ID: 6601057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural comparison of I-A antigens produced by a cloned murine T suppressor cell line with B-cell-derived I-A.
    Koch N; Arnold B; Hämmerling GJ; Heuer J; Kölsch E
    Immunogenetics; 1983; 17(5):497-505. PubMed ID: 6220968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody recognizing HLA-DR2 on malignant and activated cells.
    Fuggle SV; Kirkley J; Ting A; Morris PJ
    Immunogenetics; 1983; 18(4):415-28. PubMed ID: 6195109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Ia-positive mouse T-cell clone is functional in presenting antigen to other T cells.
    Ben-Nun A; Strauss W; Leeman SA; Cohn LE; Murre C; Duby A; Seidman JG; Glimcher LH
    Immunogenetics; 1985; 22(2):123-30. PubMed ID: 3875550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA-DR antigens: cellular expression and molecular structure].
    Charron DJ
    Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analytical microelectrophoresis of cells and the means for using it in oncological research].
    Novichenko NL; Struk VI
    Eksp Onkol; 1985; 7(3):21-6, 30. PubMed ID: 3893971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of DR-like molecules on a marmoset Epstein-Barr virus-induced cell line using a monomorphic anti-human HLA-DR monoclonal antibody.
    Teillaud JL; Charron D; Goujet-Zalc C; Mahouy G
    Eur J Immunol; 1982 May; 12(5):446-8. PubMed ID: 6284521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
    Demotz S
    Eur J Immunol; 1993 Sep; 23(9):2100-8. PubMed ID: 8370392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical comparison of HLA-DR molecules derived from autologous human T and B lymphoblasts.
    Altevogt P; Fohlman J; Kurnick JT; Peterson P; Wigzell H
    Eur J Immunol; 1980 Dec; 10(12):908-14. PubMed ID: 6258924
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.